Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EUM

CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH DZ-307

Summary for 6EUM
Entry DOI10.2210/pdb6eum/pdb
Related4TYT 5JMX
DescriptorMetallo-beta-lactamase type 2, ZINC ION, SULFATE ION, ... (6 entities in total)
Functional Keywordsantimicrobial resistance, metallo beta lactamase, inhibitor, hydrolase
Biological sourceBacillus cereus
Total number of polymer chains1
Total formula weight25656.80
Authors
Stepanovs, D.,McDonough, M.A.,Schofield, C.J.,Zhang, D.,El-Husseiny, A.,Brem, J. (deposition date: 2017-10-30, release date: 2018-10-03, Last modification date: 2024-11-13)
Primary citationZhang, D.,Markoulides, M.S.,Stepanovs, D.,Rydzik, A.M.,El-Hussein, A.,Bon, C.,Kamps, J.J.A.G.,Umland, K.D.,Collins, P.M.,Cahill, S.T.,Wang, D.Y.,von Delft, F.,Brem, J.,McDonough, M.A.,Schofield, C.J.
Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-beta-lactamases.
Bioorg. Med. Chem., 26:2928-2936, 2018
Cited by
PubMed Abstract: Metallo-β-lactamases (MBLs) enable bacterial resistance to almost all classes of β-lactam antibiotics. We report studies on enethiol containing MBL inhibitors, which were prepared by rhodanine hydrolysis. The enethiols inhibit MBLs from different subclasses. Crystallographic analyses reveal that the enethiol sulphur displaces the di-Zn(II) ion bridging 'hydrolytic' water. In some, but not all, cases biophysical analyses provide evidence that rhodanine/enethiol inhibition involves formation of a ternary MBL enethiol rhodanine complex. The results demonstrate how low molecular weight active site Zn(II) chelating compounds can inhibit a range of clinically relevant MBLs and provide additional evidence for the potential of rhodanines to be hydrolysed to potent inhibitors of MBL protein fold and, maybe, other metallo-enzymes, perhaps contributing to the complex biological effects of rhodanines. The results imply that any medicinal chemistry studies employing rhodanines (and related scaffolds) as inhibitors should as a matter of course include testing of their hydrolysis products.
PubMed: 29655609
DOI: 10.1016/j.bmc.2018.02.043
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.18 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon